---
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295144803.md"
description: "Health Catalyst shares are trading lower after the company issued Q3 sales and FY2026 sales guidance below estimates."
datetime: "2026-08-06T21:11:18.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295144803.md)
  - [en](https://longbridge.com/en/news/295144803.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295144803.md)
generator: "portal-rs"
---

# 

Health Catalyst shares are trading lower after the company issued Q3 sales and FY2026 sales guidance below estimates.

### Related Stocks

- [HCAT.US](https://longbridge.com/en/quote/HCAT.US.md)

## Related News & Research

- [Health Catalyst Q2 adjusted EBITDA beats estimates](https://longbridge.com/en/news/295140300.md)
- [HCAT: Q2 2026 beat guidance, divestiture enabled debt repayment, and 2026 outlook reflects transformation](https://longbridge.com/en/news/295151417.md)
- [Ryan L. Vardeman discloses investment at Health Catalyst with 6.7% stake](https://longbridge.com/en/news/290473850.md)
- [Health Catalyst (NASDAQ:HCAT) Issues Quarterly Earnings Results, Beats Estimates By $0.01 EPS](https://longbridge.com/en/news/295309652.md)
- [Med-Metrix Enters Into Definitive Agreement to Acquire Vitalware to Enhance Coding Accuracy and Net Revenue Yield](https://longbridge.com/en/news/288736474.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**